Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px
Document › Details

Element Biosciences, Inc.. (6/26/20). "Press Release: Element Raises $30M in Additional Series B Financing to Accelerate Development of a New Sequencing Platform".

Organisations Organisation Element Biosciences Inc.
  Organisation 2 RA Capital Management L.P.
Products Product DNA sequencing technology
  Product 2 venture capital
Index terms Index term Element Biosciences–SEVERAL: investment, 202006 financing round Series B extension $30m with new investors RA Capital + Alexandria VI
  Index term 2 Element Biosciences–Alexandria Real Estate: investment, 202006 financing round Series B extension totalling $30m incl new investor Alexandria VI
     



Element Biosciences raised an additional $30M in Series B financing, with participation from new investors RA Capital Management and Alexandria Venture Investments. Proceeds from the financing will be used to accelerate the development of a new DNA sequencing platform. To date, the company has raised a total of more than $130M.

   
Record changed: 2023-06-05

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Element Biosciences Inc.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x300px




» top